Blood Pressure News and Research

RSS

Blood Pressure is the force of circulating blood on the walls of the arteries. Blood pressure is taken using two measurements: systolic (measured when the heart beats, when blood pressure is at its highest) and diastolic (measured between heart beats, when blood pressure is at its lowest). Blood pressure is written with the systolic blood pressure first, followed by the diastolic blood pressure (for example 120/80).

Majority of Canadians' diets have high salt content

Canadians know that too much salt isn't good for their diets, but half still continue to shake it on, according to a new study by University of Alberta researchers.

18 Nov 2009

FDA approves Qutenza, a pain relief product for patients who suffer from PHN

The Food and Drug Administration (FDA) has approved the approval of Qutenza (capsaicin) 8% patch, a medicated skin patch that relieves the pain of post-herpetic neuralgia (PHN), a serious complication that can occur after a bout with shingles.

18 Nov 2009

Depression is as much of a risk factor for mortality as smoking, says new study

A study by researchers at the University of Bergen, Norway, and the Institute of Psychiatry (IoP) at King's College London has found that depression is as much of a risk factor for mortality as smoking.

17 Nov 2009

Technology to help elderly people stay healthy at home

In a collaboration between Kaiser Health News and The Washington Post, Elizabeth Olson writes about how emerging technology is helping older people stay in their homes and can, in some instances, offer mechanisms to improve patient outcomes and reduce health care costs.

17 Nov 2009

Non-clinical data from Cytokinetics' smooth muscle contractility program presented

Cytokinetics, Incorporated announced today that three abstracts summarizing non-clinical data regarding its smooth muscle contractility program were presented at the 2009 Scientific Sessions of the American Heart Association in Orlando, Florida.

17 Nov 2009

First Edition: November 17, 2009

Based on today's headlines, all eyes continue to be focused on the Senate -- where Democratic leaders are still waiting for the revised Congressional Budget Office analysis of their health bill and plotting about when to hold the first procedural vote on the measure.

17 Nov 2009

Consortium to define new modalities for treating hypertension and associated vascular complications

Top Institute Pharma has formed a consortium with Actelion Pharmaceuticals Ltd, Erasmus Medical Centre and Maastricht University to define new modalities for the treatment of hypertension (high blood pressure) and associated vascular complications such as heart and kidney failure, myocardial infarction and stroke.

17 Nov 2009

Health Net’s MA product portfolio offers budget-friendly health plan choices to beneficiaries for 2010

With the kick-off of the Medicare Annual Election Period (AEP) this week, Health Net, Inc. reminds those eligible for Medicare that Health Net’s Medicare Advantage (MA) product portfolio offers a comprehensive range of budget-friendly health plan choices to beneficiaries for 2010.

17 Nov 2009

AACR-NCI-EORTC conference highlights major expansion in cancer drug pipeline

To highlight results of more recent research, the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics International Conference will host a press briefing on "Drugs in the Pipeline." Sara A. Courtneidge, Ph.D., D.Sc., professor and director of the Tumor Microenvironment Program, and director of academic affairs at the Burnham Institute for Medical Research, will moderate this press briefing.

17 Nov 2009

Global Alliance for Chronic Disease to fight against chronic non-communicable diseases

An alliance of institutions collectively managing an estimated 80 percent of all public health research funding worldwide today announced their first targets for concerted action in the fight against "chronic non-communicable diseases" (CNCDs).

17 Nov 2009

Shire publishes new study results on INTUNIV Extended-Release Tablets

Shire plc, the global specialty biopharmaceutical company, announced new study results on INTUNIV- (guanfacine) Extended-Release Tablets published in the October Journal of Child and Adolescent Psychopharmacology. In this open-label safety study, there was no evidence of unique adverse effects with the combination of INTUNIV and amphetamine or methylphenidate relative to what was observed with either medication alone.

17 Nov 2009

VCU and RAA have improved resuscitation and survival rates for cardiac arrest patients

Virginia Commonwealth University Medical Center and the Richmond Ambulance Authority have improved resuscitation and survival rates dramatically for cardiac arrest patients by training and equipping paramedics to begin lowering a patient's body temperature in the field during resuscitation and following up at the hospital with a host of high-tech strategies to improve the odds of survival.

17 Nov 2009

Genentech submits sBLAs to the FDA for Avastin

Genentech, Inc., a wholly-owned member of the Roche Group, today announced that the company submitted two supplemental Biologics License Applications (sBLAs) to the U.S. Food and Drug Administration (FDA) for Avastin® (bevacizumab) for the treatment of women who have not received chemotherapy for advanced (metastatic) HER2-negative breast cancer (first-line treatment). One sBLA is based on the Phase III study AVADO that investigated Avastin in combination with docetaxel chemotherapy.

17 Nov 2009

FDA approves NeurogesX's Qutenza patch for postherpetic neuralgia treatment

NeurogesX, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Qutenza(TM) (capsaicin) 8% patch, the first and only product containing prescription strength capsaicin, for the management of neuropathic pain due to postherpetic neuralgia (PHN), the nerve pain which can follow shingles.

17 Nov 2009

EKG may not always be correct

The electrical measurements on the electrocardiogram can often mislead physicians in diagnosing the heart condition left ventricular hypertrophy, causing other screening tests to be ordered before a definitive conclusion can be made, according to a Henry Ford Hospital study.

17 Nov 2009

Statin therapy should still be used first to reach blood cholesterol levels before considering niacin

Heart experts at Johns Hopkins are calling premature the early halt of a study by researchers at Walter Reed Army Medical Center and Washington Hospital Center on the benefits of combining extended-release niacin, a B vitamin, with cholesterol-lowering statin medications to prevent blood vessel narrowing. Cardiovascular atherosclerosis, as it is also known, is believed responsible for one in three deaths in the United States each year.

17 Nov 2009

HealthTrans Access sponsors 50 disadvantaged families to free healthcare support

HealthTrans Access, a comprehensive discount healthcare provider, has arranged for 50 disadvantaged families from the Greater Denver and Boulder areas to receive one year of membership in the HealthTrans Access discount healthcare program at no cost. In partnership with Denver Human Services and several of their community organizations, HealthTrans Access is providing families with its Premium discount program, which provides deep discounts for healthcare services for the entire family.

17 Nov 2009

Migraine headaches linked with increased risk of common kind of stroke

Pooling results from 21 studies, involving 622,381 men and women, researchers at Johns Hopkins have affirmed that migraine headaches are associated with more than twofold higher chances of the most common kind of stroke: those occurring when blood supply to the brain is suddenly cut off by the buildup of plaque or a blood clot.

16 Nov 2009

China Medicine reports total revenues of $19.2M for the third quarter of 2009

China Medicine Corporation, a developer and a leading distributor of prescription and over-the-counter pharmaceuticals, traditional Chinese medicines (TCM), nutritional and dietary supplements, and medical devices and medical formulations, today announced its third quarter 2009 results.

16 Nov 2009

Mayo Clinic Health Letter provides treatment options for people with heart disorders

Fewer than one-third of patients with heart failure are taking the three types of medications that are most effective in prolonging life and improving quality of life. The November issue of Mayo Clinic Health Letter provides an overview of treatments recommended by national guidelines.

16 Nov 2009

Blood Pressure News and Research

Further Reading

Majority of Canadians' diets have high salt content

FDA approves Qutenza, a pain relief product for patients who suffer from PHN

Depression is as much of a risk factor for mortality as smoking, says new study

Technology to help elderly people stay healthy at home

Non-clinical data from Cytokinetics' smooth muscle contractility program presented

First Edition: November 17, 2009

Consortium to define new modalities for treating hypertension and associated vascular complications

Health Net’s MA product portfolio offers budget-friendly health plan choices to beneficiaries for 2010

AACR-NCI-EORTC conference highlights major expansion in cancer drug pipeline

Global Alliance for Chronic Disease to fight against chronic non-communicable diseases

Shire publishes new study results on INTUNIV Extended-Release Tablets

VCU and RAA have improved resuscitation and survival rates for cardiac arrest patients

Genentech submits sBLAs to the FDA for Avastin

FDA approves NeurogesX's Qutenza patch for postherpetic neuralgia treatment

EKG may not always be correct

Statin therapy should still be used first to reach blood cholesterol levels before considering niacin

HealthTrans Access sponsors 50 disadvantaged families to free healthcare support

Migraine headaches linked with increased risk of common kind of stroke

China Medicine reports total revenues of $19.2M for the third quarter of 2009

Mayo Clinic Health Letter provides treatment options for people with heart disorders

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News